APERIOLIVE
DEAD

Serial Number

85580676

Owner

OPTUMINSIGHT, INC.

Attorney

Joseph V. Myers

First Use Date

Feb 14, 2012

Filing Date

Mar 27, 2012

Add to watchlist:

No watchlists yet
View on USPTO

APERIOLIVE Trademark

Serial Number: 85580676 • Registration: 4356385

APERIOLIVE is a trademark filed by OPTUMINSIGHT, INC. on March 27, 2012. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

OPTUMINSIGHT, INC. (47 trademarks)

13625 TECHNOLOGY DRIVE
EDEN PRAIRIE, MN 55344

Entity Type: 03

Trademark Details

Filing Date

March 27, 2012

Registration Date

June 25, 2013

First Use Anywhere

February 14, 2012

First Use in Commerce

February 14, 2012

Published for Opposition

April 9, 2013

Cancellation Date

January 31, 2020

Goods & Services

Medical care data analysis services, namely, capturing and analyzing health care information for medical providers to help them improve patient care

Providing an online database in the field of pharmaceutical product analysis for the pharmaceutical industry, namely, a database providing performance metrics, including drug safety, based on the analysis of integrated medical and pharmacy claims data to track and assess the potential health risks of new or existing pharmaceutical products in the field of pharmaceutical research; application service provider (ASP) featuring software platform for comprehensive pharmaceutical risk management program, namely, a pharmaceutical product safety surveillance tool; application service provider (ASP) featuring software platform containing a large scale registry that mines a proprietary database containing deidentified health care and pharmaceutical claims data, health care and laboratory results, pharmacy data, demographic and socioeconomic data; application service provider (ASP) featuring software containing pharmaceutical risk management tools, namely, standard tables of new molecular entities and selected comparators, comparisons of customized drug pairs; providing scientific consulting services in the field of pharmaceutical research; preparing scientific reports for the pharmaceutical industry and regulatory agencies

Filing History

CANCELLED SEC. 8 (6-YR)
Jan 31, 2020 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jun 25, 2018 REM1
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 26, 2013 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 26, 2013 REAP
REGISTERED-PRINCIPAL REGISTER
Jun 25, 2013 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2013 TCCA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 9, 2013 NPUB
PUBLISHED FOR OPPOSITION
Apr 9, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 20, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 5, 2013 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 4, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 1, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 28, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 28, 2013 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 16, 2013 GNRN
NON-FINAL ACTION E-MAILED
Jan 16, 2013 GNRT
NON-FINAL ACTION WRITTEN
Jan 16, 2013 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 16, 2013 ZZZX
ASSIGNED TO LIE
Jan 11, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 21, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 20, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 19, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 19, 2012 TROA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 28, 2012 ASGN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 5, 2012 GNRN
NON-FINAL ACTION E-MAILED
Jul 5, 2012 GNRT
NON-FINAL ACTION WRITTEN
Jul 5, 2012 CNRT
ASSIGNED TO EXAMINER
Jul 5, 2012 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 2, 2012 NWOS
NEW APPLICATION ENTERED
Mar 30, 2012 NWAP